Cellular and metabolic consequences of chronic ischemia on kidney function

Seminars in Nephrology

Volumn 16, Issue 1, 1996, Pages 33-42

  Kellerman, Paul S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CHRONIC KIDNEY FAILURE; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; NONHUMAN; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CHRONIC DISEASE; HEMODYNAMIC PROCESSES; HUMANS; ISCHEMIA; KIDNEY; NITRIC OXIDE;

EID: 0030046005     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Jacobson HR: Ischemie renal disease: An overlooked clinical entity? Kidney Int 34:729-743, 1988
2. Rimmer JM, Gennari FJ: Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 118: 712-719, 1993
3. Harding MB, Smith LR, Himmelstein SI, et al: Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol2:l608-1616, 1992
4. U.S. Renal Data Systems, USRDS 1991 Annual Report: Executive summary, Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, August, 1991, p3
5. Mailloux LU, Bellucci AG, Mossey RT, et al: Predictors of survival in patients undergoing dialysis. Am J Med 84:855-862, 1988
6. Scoble JE, Maher ER, Hamilton G, et al: Atherosclerotic renovascular disease causing renal failure - A case for treatment. Clin Nephrol 31:119-122, 1989
7. Textor SC, Tarazi RC, Klimas V, et al: Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 102:308-314, 1985
8. Taylor A, Eshima D: Renal artery stenosis and ischemia. Effect on renal blood flow and extraction fraction. Hypertension 23:96-103, 1994
9. Ying CY, Tifll CP, Gavras H, et al: Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 311:1070-1075, 1984
10. Nielsen K, Rehling M, Henriksen JH: Renal vein oxygen saturation in renal artery stenosis. Clin Physiol 12:179-184, 1992
11. Rahimtoola SH: The hibernating myocardium. Am Heart J 117:211-220, 1989
12. Zhang J, Path G, Chepuri V, et al: Responses of myocardial high energy phosphates and wall thickening to prolonged regional hypoperfusion induced by subtotal coronary stenosis. Magn Reson Med 30:28-37, 1993
13. Goldblatt H, Lynch J, Hanzal RF, et al: Studies on experimental hypertension. 1. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59:347-379, 1934
14. Textor SC, Smith-Powell L: Post-stenotic arterial pressures, renal haemodynamics and sodium excretion during graded pressure reduction in conscious rats with one- and two-kidney coarctation hypertension. J Hypertens 6:311-319, 1988
15. Shehata M, El Nahas AM, Barkworth E, et al: Increased platelet-derived growth factor in the kidneys of cyclosporintreated rats. Kidney Int 46:726-732, 1994
16. Sigmon DH, Beierwaltes WH: Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension 22:237-242, 1993
17. Myers BD, Deen WM, Brenner BM: Effects of nor-epinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule reabsorption in the rat. Circ Res 37:101-110, 1975
18. Hricik DE, Brownin PJ, Kopelman R, et al: Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med 308:373-376, 1983
19. Grone JH, Helmchen U: Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy. Lab Invest 54:645655, 1986
20. Michel JB, Dussale JC, Choudat L, et al: Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats. Kidney Int 29:1011-1020, 1986
21. Jackson B, Fanze L, Sumithran E, et al: Pharmacologie nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. J Lab Clin Med 115:21-27, 1990
22. Anderson WP, Denton KM, Woods RL, et al: Angiotensin II and the maintenance of GFR and renal blood flow during renal artery narrowing. Kidney Int 38:5-109-5-113, 1990(suppl30)
23. Mai M, Hilgers KF, Wagner J, et al: Expression of angiotensin-converting enzyme in renovascular hypertensive rat kidney. Hypertension 251:674-678, 1995
24. Ploth DW: Influences of angiotensin on renal function in renal vascular hypertension. Kidney Int 38:5-97-5-101,1990 (suppl 30)
25. Vercellotti GM, Tolins JP: Endothelial activation and the kidney: Vasomediator modulation and antioxidant strategies. Am J Kidney Dis 21:331 -343, 1993
26. Bloom IT, Bentley FR, Wilson MA, et al: In vivo effects of endothelin on the renal microcirculation. J Surg Res 54: 274-280, 1993
27. Gellai M, Jugus M, Fletcher T, et al: Reversal of postischemic acute renal failure with a selective endothelin receptor antagonist in the rat. J Clin Invest 93:900-906, 1994
28. Kon V, Sugiura M, Inagami T, et al: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37:1487-1491, 1990
29. Lanese DM, Conger JD: Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 91:2144-2149, 1993
30. Levy M: Hepatorenal syndrome. Kidney Int 43:737753,1993
31. Moore K, Wendon J, Frazer M, et al: Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327:1774-1778, 1992
32. Lerman A, Edwards BS, Hallett JW, et al: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325:997-1001, 1991
33. Sorensen 55, Egeblad M, Eiskjaer H, et al: Endothelin in renovascular and essential hypertension. Blood Pressure 3: 364-369, 1994
34. Sigmon DH, Beierwaltes WH: Endothelium-derived constricting factor in renovascular hypertension. Hypertension 25:803-808, 1995
35. Sigmon DH, Beierwaltes WH: Degree of renal artery stenosis alters nitric oxide regulation of renal hemodynamics. J Am Soc Nephrol 5:1369-1377, 1994
36. Bobadilla NA, Tapia E, Franco M, et al: Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity. Kidney Int 46:773-779, 1994
37. Morikawa E, Moskowitz MA, Huang Z, et al: L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25:429-435, 1994
38. Sancesario G, lannone M, Morello M, et al: Nitric oxide inhibition aggravates ischemie damage in hippocampal but not NADPH neurons in gerbils. Stroke 25:436-443, 1994
39. Nakamoto M, Shapiro JI, Shanley PF, et al: In vitro and in vivo protective effect of atriopeptin HI on ischemie acute renal failure. J Clin Invest 80:698-705, 1987
40. Rahman SN, Kirn GE, Mathew AS, et al: Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45:1731-1738, 1994
41. Tunny TJ, Gordon RD, Klemm SA, et al: Renal extraction of atrial natriuretic peptide in unilateral renal artery stenosis. Clin Exp Pharmacol Physiol 21:211-214, 1994
42. Bruun NE, Rehling M, Kanstrup IL, et al: Unchanged extraction of atrial natriuretic factor across the chronic ischemie human kidney. J Hypertens 9:35-40, 1991
43. Bokemeyer D, Friedrichs U, Backer A, et al: Atrial natriuretic peptide inhibits cyclosporin A-induced endothelin production and calcium accumulation in rat vascular smooth muscle cells. Clin Sei 87:383-387, 1994
44. Soejima H, Nomura Y, Tsuruta K, et al: Intrarenal prostaglandins E2 and F2 alpha in experimental renovascular hypertension. Urol Int 36:158-165, 1981
45. Kellerman PS, Norenberg SL: Proximal tubule F-actin polymerizes and moves apically in a time-dependent manner during reperfusion following ischemia. J Am Soc Nephrol 2: 649, 1991 (abstr)
46. Warnick CT, Lazarus HM: Recovery of nucleotide levels after cell injury. Can J Biochem 59:16-21, 1981
47. McCoy CE, Selvaggio AM, Alexander EA, et al: Adenosine triphosphate depletion induces a rise in cytosolic free calcium in canine renal epithelial cells. J Clin Invest 82:1326-1332,1988
48. Snowdowne KW, Freudenrich CC, Borle AB: The effects of anoxia on cytosolic free calcium, calcium fluxes, and cellular ATP levels in cultured kidney cells. J Biol Chem 260: 11619-11626, 1985
49. Venkatachalam MA, Patel YJ, Kreisberg JI, et al: Energy thresholds that determine membrane integrity and injury in a renal epithelial cell line (LLC-PK1). Relationships to phospholipid degradation and unesterified fatty acid accumulation. J Clin Invest 81:745-758, 1988
50. 2 enzymatic activity after renal ischemia and reperfusion. J Clin Invest 87:1810-1818, 1991
51. 2-induced rabbit renal proximal tubule cell injury. J Clin Invest 82:1098-1105, 1988
52. Kellerman PS, Bogusky RT: Microfilament disruption occurs very early in ischemie proximal tubule cell injury. Kidney Int 42:896-902, 1992
53. Kellerman PS: Exogenous adenosine triphosphate (ATP) preserves proximal tubule microfilament structure and function in vivo in a maleic acid model of ATP depletion. J Clin Invest 92:1940-1949, 1993
54. Kroshian VM, Sheridan AM, Lieberthal W: Functional and cytoskeletal changes induced by sublethal injury in proximal tubular epithelial cells. Am J Physiol 266:F21-F30,1994
55. Molitoris BA, Wilson PD, Schrier RW, et al: Ischemia induces partial loss of surface membrane polarity and accumulation of putative calcium ionophores. J Clin Invest 76: 2097-2105, 1985
56. Palier MS, Hebbel RP: Ethane production as a measure of lipid peroxidation after renal ischemia. Am J Physiol 251: F839-F843, 1986
57. Palier MS, Hoidal JR, Ferris TF: Oxygen free radicals in ischemie renal failure in the rat. J Clin Invest 74:1156-1164, 1984
58. Palier MS, Hedlund BE: Role of iron in postischemic renal injury in the rat. Kidney Int 34:474-480, 1988
59. Van Why SK, Mann AS, Thulin G, et al: Activation of heat-shock transcription factor by graded reductions in renal ATP, in vivo, in the rat. J Clin Invest 94:15118-1523, 1994
60. Yoshimoto Y, Kim P, Sasaki T, et al: Temporal profile and significance of metabolic failure and trophic changes in the canine cerebral arteries during chronic vasospasm after subarachnoid hemorrhage. J Neurosurg 78:807-812, 1993
61. Przyklenk K, Bauer B, Kloner RA: Reperfusion of hibernating myocardium: contractile function, high-energy phosphate content, and myocyte injury after 3 hours of sublethal ischemia and 3 hours of reperfusion in the canine model. Am Heart J 123:575-588, 1992
62. Schrier RW, Burke TJ: Role of calcium-channel blockers in preventing acute and chronic renal injury. J Cardiovasc Pharmacol 18:S38-S43, 1991 (suppl 6)
63. Ar-Rajab A, Dawidson IJA, Harris RB, et al: Deleterious effect of cyclosporines on the ischemie kidney in the rat and the protection by the calcium antagonist verapamil. J Am Soc Nephrol 5:93-101, 1994
64. Neumayer HH, Junge W, Kufner A, et al: Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial. Nephrol Dial Transplant 4:1030-1036, 1989
65. Kramer HJ, Meyer-Lehnert H, Mohaupt M: Role of calcium in the progression of renal disease: Experimental evidence. Kidney Int 41(suppl 36):S-2-S-7, 1992
66. Downey JM: Free radicals and their involvement during long term myocardial ischemia and reperfusion. Ann Rev Physiol 52:487-504, 1990
67. Nauta RJ, Tsimoyiannis E, Uribe M: Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obstet 171:120-125, 1990
68. Olanow CW: An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol 32:S2-S9, 1992
69. Truong LD, Farhood A, Tasy J, et al: Experimental chronic renal ischemia: Morphologic and immunologie studies. Kidney Int 41:1676-1689, 1992
70. Yonezawa S, Sato E, Okamoto K: Polyanion, immunoprotein and proteinase inhibitor in ischemie glomerular change. Nephron 28:105-111, 1981
71. Gobe GC, Axelsen RA, Searle JW: Cellular events in experimental unilateral ischemie renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 63:770-779, 1990
72. Allen J, Winterford C, Axelsen RA, et al: Effects of hypoxia on morphological and biochemical characteristics of renal epithelial cell and tubule cultures. Renal Failure 14:453-460, 1992
73. Schumer M, Golombel MC, Sawczuk IS, et al: Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838, 1992
74. Knecht A, Fine LG, Kleinman KS, et al: Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am J Physiol 261:F292-F299, 1991
75. Fine LG, Norman JT: Renal growth responses to acute and chronic injury: Routes to therapeutic intervention. J Am Soc Nephrol 2:S206-S211, 1992